Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

135
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
135
Rh Blood Group01:19

Rh Blood Group

1.4K
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
1.4K
Hemoglobin01:24

Hemoglobin

3.4K
Hemoglobin is a globular protein made up of four subunits. Two of these subunits are alpha chains, and the other two are beta chains. Each subunit contains a molecule of heme, which has an iron atom and can bind to oxygen. When an oxygen molecule binds to one heme group, it changes the shape of hemoglobin, making it easier for the other heme groups to bind oxygen as well.
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
3.4K
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

873
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
873
Oxygen Transport in the Blood01:27

Oxygen Transport in the Blood

2.5K
Hemoglobin (Hb) is a crucial molecule in the human body, consisting of four polypeptide chains, each bound to an iron-containing heme group. This unique structure enables hemoglobin to bind to oxygen, with each molecule capable of combining with four molecules of oxygen, leading to rapid and reversible oxygen loading. When fully loaded with oxygen, it is called oxyhemoglobin, while hemoglobin that has released oxygen is called reduced hemoglobin or deoxyhemoglobin. As hemoglobin binds oxygen,...
2.5K
Hypoxia01:23

Hypoxia

943
Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
943

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A 7-Year-Old Boy with Prolonged Fever.

NEJM evidence·2025
Same author

Management of Spontaneous Epidural Hematoma in the Setting of Vaso-occlusive Crisis Among Pediatric Patients With Sickle Cell Disease: A Case Series and Scoping Literature Review.

Journal of pediatric hematology/oncology·2024
Same author

Prevent Acute Chest Syndrome checklist (PACScheck): A quality improvement initiative to reduce acute chest syndrome.

Pediatric blood & cancer·2024
Same author

Point-of-Care Ultrasound for the General Pediatric Resident: A Needs Assessment.

Clinical pediatrics·2024
Same author

Finding pediatric thromboembolism: needles in a big data haystack.

Pediatric research·2024
Same author

Associating a standardized reporting tool for chest radiographs with clinical complications in pediatric acute chest syndrome.

Pediatric pulmonology·2023

Related Experiment Video

Updated: Jun 9, 2025

Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin
07:57

Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin

Published on: August 25, 2022

2.8K

Hemoglobinopathies in the Neonate.

Katrina Blankenhorn1, Kaitlin Strumph1

  • 1Division of Hematology/Oncology, Department of Pediatrics, Children's Hospital at Montefiore, Albert Einstein College of Medicine, New York, NY.

Neoreviews
|October 31, 2024
PubMed
Summary
This summary is machine-generated.

Neonatal hemoglobinopathies, caused by genetic mutations, include thalassemias and sickle cell disease. This review covers their epidemiology, genetics, presentation, and management in newborns.

More Related Videos

Biochemical Measurement of Neonatal Hypoxia
13:13

Biochemical Measurement of Neonatal Hypoxia

Published on: August 24, 2011

14.0K
A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

1.7K

Related Experiment Videos

Last Updated: Jun 9, 2025

Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin
07:57

Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin

Published on: August 25, 2022

2.8K
Biochemical Measurement of Neonatal Hypoxia
13:13

Biochemical Measurement of Neonatal Hypoxia

Published on: August 24, 2011

14.0K
A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

1.7K

Area of Science:

  • Genetics
  • Neonatal Medicine
  • Hematology

Background:

  • Hemoglobinopathies are genetic disorders affecting human globin genes, categorized as quantitative (thalassemias) or qualitative (e.g., sickle cell disease).
  • The switch from fetal to adult globin chains during the perinatal period impacts the timing of clinical presentation and diagnosis.
  • Understanding these disorders is crucial for timely intervention in neonates.

Purpose of the Study:

  • To provide a comprehensive overview of common hemoglobinopathies in the neonatal period.
  • To review the epidemiology, genetic causes, and clinical presentation of these disorders.
  • To discuss the general management strategies for neonatal hemoglobinopathies.

Main Methods:

  • This is a review article, synthesizing existing literature.
  • Focuses on common hemoglobin disorders encountered in neonates.
  • Covers epidemiology, genetic basis, clinical features, and management.

Main Results:

  • Hemoglobinopathies present with quantitative (thalassemias) or qualitative (sickle cell disease) defects due to globin gene mutations.
  • The perinatal globin chain switch influences disease manifestation and diagnostic timing.
  • Common disorders include alpha-thalassemia, beta-thalassemia, and sickle cell disease.

Conclusions:

  • Early identification and management of neonatal hemoglobinopathies are essential for improving outcomes.
  • Genetic counseling and newborn screening are vital components of care.
  • Further research into novel therapeutic approaches is warranted.